Cardiovascular-Renal Adverse Prognosis Assessment System for Coronary Heart Disease With Chronic Kidney Disease Based on Metabolomics

RecruitingOBSERVATIONAL
Enrollment

470

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Chronic Kidney DiseasesCoronary Heart DiseaseLipid Metabolism Disorders
Interventions
DIAGNOSTIC_TEST

lipid metabolomics

Extract 4 milliliters of fasting peripheral venous blood from enrolled patients for targeted lipid metabolism metabolomics research. Utilize a liquid chromatography-tandem mass spectrometry (LC-MS/MS) system to conduct metabolomics analysis on patient blood samples.

Trial Locations (1)

Unknown

RECRUITING

China-Japan Friendship Hospital, Beijing

All Listed Sponsors
lead

China-Japan Friendship Hospital

OTHER